On Day 1 at JPM, Chris Viehbacher, a 35-year pharma vet, offered color on getting Biogen’s house in order, from M&A to the Leqembi launch to winding down MS marketing.
Can an in-person JPM supercharge biopharma deal-making?
Given the progressive decline in the number of physicians deemed accessible over the last decade, marketers need to think of new digital-driven ways to reach them.
Using POC marketing to spark joy on first day of Digital Pharma East 2022